Search - tctmd.com

Displaying 81 - 96 of 96

Sort: Relevancy | Date

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

Pro: Prasugrel!

Presenter: Giuseppe Biondi Zoccai

October 23, 2012

Presentation TCT 2012

PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers

Presenter: Paul Gurbel

October 22, 2012

Presentation TCT 2012

A Prospective, Randomized Trial of Tailored Clopidogrel Therapy vs. Prasugrel in Patients with High On-Treatment Platelet Reactivity

Presenter: Laurent Bonello

October 22, 2012

Presentation

Reduction in Platelet Reactivity with Prasugrel 5 mg in Low-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Weight Patients

Presenter: David Erlinge

October 17, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

Presentation

Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI

Presenter: Dimitrios Alexopoulos

July 09, 2012

Presentation

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Presenter: Matthew J. Price

June 13, 2012

Presentation

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Presenter: 195949|Peter Smith

May 25, 2012

Presentation

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Pts on Maintenance Prasugrel Therapy

Presenter: A. Tello-Montoliu

April 30, 2012

Presentation

A Randomized Trial of Prasugrel vs. Clopidogrel in Patients with High Platelet Reactivity on Clopidogrel After Elective PCI with DES

Presenter: Dietmar Trenk

April 18, 2012

Presentation ACC 2012

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Presenter: Gennaro Sardella

March 24, 2012

Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

Presenter: Fr?d?ric Casassus, Lionel Leroux, Chloe James, Sali Sidibe, Agnalys Desplantes, David Naibo, Benjamin Seguy, Pierre Chevallereau, Pierre Coste

January 03, 2012

Presentation TCT 2012

In-Hospital Experience of 'Real World' Patients Enrolled in the TAXUS Liberte Post-Approval Study: The TAXUS Liberte Stent with Concomitant Prasugrel Therapy

Presenter: David P. Lee, Kirk N. Garratt, Richard Paulus, Jeffrey Carr, Kartik Giri, Ameer Kabour, Kenneth J. Winters, Thomas S. Bowman, Keith D. Dawkins

January 03, 2012

Presentation TCT 2012

Comparison of bivalirudin versus heparin during PCI in patients receiving prasugrel M Hamon, S Marso, SV Rao, M Valgimigli, F Verheugt, A Gershlick, Y Wang, GP Steg, E...

Presenter: Martial Hamon

January 03, 2012

Advertisement

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Pro: Prasugrel!

PARADOX: A Prospective, Randomized Trial of Clopidogrel and Prasugrel in Smokers and Non-Smokers

A Prospective, Randomized Trial of Tailored Clopidogrel Therapy vs. Prasugrel in Patients with High On-Treatment Platelet Reactivity

Reduction in Platelet Reactivity with Prasugrel 5 mg in Low-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Weight Patients

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Ticagrelor vs. Prasugrel in ACS Patients with High On-Clopidogrel Platelet Reactivity Following PCI

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Pts on Maintenance Prasugrel Therapy

A Randomized Trial of Prasugrel vs. Clopidogrel in Patients with High Platelet Reactivity on Clopidogrel After Elective PCI with DES

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

In-Hospital Experience of 'Real World' Patients Enrolled in the TAXUS Liberte Post-Approval Study: The TAXUS Liberte Stent with Concomitant Prasugrel Therapy

Comparison of bivalirudin versus heparin during PCI in patients receiving prasugrel M Hamon, S Marso, SV Rao, M Valgimigli, F Verheugt, A Gershlick, Y Wang, GP Steg, E...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content